The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

Pharmaceutical companies protecting their profits through patent protection laws, which prevent other countries from producing generic versions of the COVID vaccine, are the greatest obstacles to a more efficient global distribution of vaccines.